You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Drugs Containing Excipient (Inactive Ingredient) SODIUM IODIDE


✉ Email this page to a colleague

« Back to Dashboard


Last updated: February 4, 2026

mmary
The demand for sodium iodide as a pharmaceutical excipient remains stable, driven by its medical applications and iodine deficiency correction. Market growth is moderate, with a compound annual growth rate (CAGR) estimated at 3-4% over the next five years. The market is influenced by factors such as increased iodine deficiency awareness, expanding applications in diagnostic imaging, and regulatory standards. Price trends remain steady, with raw material costs and regulatory compliance affecting margins.


What Are the Key Drivers of Sodium Iodide Market Growth?

Medical and Diagnostic Applications

Sodium iodide’s primary use in medicine is as a radiocontrast agent and in the treatment of iodine deficiency. It is essential for manufacturing radioactive iodine isotopes used in diagnostic imaging of the thyroid (such as radioactive iodine therapy). The proliferation of nuclear medicine procedures supports steady demand.

Growing Iodine Deficiency Awareness

Iodine deficiency affects over 1 billion people globally, prompting public health initiatives. Countries fortify salt with iodine, increasing raw material demand for sodium iodide production.

Regulatory Environment and Standards

The United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other standards govern pharmaceutical-grade sodium iodide. Regulations favor high purity and quality, fostering consistent demand but also creating barriers for lower-grade imports.

Expansion into New Markets

Research into sodium iodide’s role in cancer treatment and nuclear imaging expands potential uses. The pharmaceutical industry explores formulation innovations, potentially broadening application scope.


What Are the Market Size and Projected Growth Trajectory?

Year Estimated Global Market Value CAGR (2018-2023) Main Drivers
2023 USD 150 million 3-4% Medical applications, iodine deficiency
2025 USD 160-165 million Increased diagnostic procedures
2028 USD 180-200 million Expanded research and diagnostics

Data from industry reports (e.g., Mordor Intelligence, 2022) shows steady expansion, primarily in North America and Europe, with emerging markets in Asia Pacific showing faster growth prospects.


What Factors Influence Pricing and Margins?

  • Raw Material Costs: Iodine price fluctuations, affected by geopolitical tensions, mining yields, and supply chain issues, directly impact sodium iodide prices.
  • Purity Standards: Higher purity grades for pharmaceutical use command higher prices, with quality assurance costs affecting margins.
  • Regulatory Compliance: Costs associated with GMP compliance and certifications influence production cost structures.
  • Competition: A limited number of producers in China, India, and Europe maintains relatively stable pricing; oversupply risks exist if new manufacturing plants come online.

Price Trends (Estimated)

Market prices for pharmaceutical-grade sodium iodide hover around USD 15-25 per kilogram. Variations depend on purity and concentration requirements.


What Are the Challenges Facing the Sodium Iodide Market?

  • Supply Chain Disruptions: Global shortages of iodine, especially those linked to geopolitical conflicts or health crises, can constrain supply.
  • Regulatory Stringency: Evolving standards require ongoing investment in quality controls, which may increase production costs.
  • Competition from Alternatives: Although sodium iodide is the preferred agent for specific diagnostic uses, other formulations and isotopes may supplant its role in niche markets.
  • Environmental and Sustainability Concerns: The mining and processing of iodine raise regulatory and ethical issues, potentially limiting supply and increasing costs.

How Do Geopolitical and Policy Factors Impact the Market?

Countries with rich iodine deposits—such as Chile, Japan, and the United States—control significant supply chains. Export restrictions, tariffs, or political instability pose risks. International agreements on nuclear materials influence demand for sodium iodide in nuclear medicine applications, as some regions restrict or monitor procurement closely.

Trade tensions between major producers and importing nations create pricing volatility. Recent disruptions in China’s supply chain have led to price spikes globally.


What Is the Competitive Landscape?

Major players include:

  • Jiangsu Yabang Pharmaceutical Group (China)
  • American Radiolabeled Chemicals (United States)
  • Jiangsu Kangle Pharmaceutical Co. (China)
  • Sigma-Aldrich (part of Merck, global)

Industry concentration is moderate, with the top five companies holding around 60% of the market share. Supply chain integration and R&D capabilities determine competitive advantages.


Future Outlook and Innovations

Research into alternative iodine sources and synthetic routes could reduce reliance on natural iodine. Advances in purification technology improve grade consistency, potentially lowering costs. Exploration of sodium iodide derivatives for targeted radiotherapy may open new markets.

Environmental standards may lead to greener extraction methods, with potential impacts on supply chain sustainability.


Key Takeaways

  • The sodium iodide market expands at a CAGR of 3-4%, driven by medical and iodine-deficiency correction uses.
  • Prices are stable but sensitive to iodine raw material fluctuations and regulatory changes.
  • Supply chains are vulnerable to geopolitical tensions and environmental policies.
  • Competition persists amid moderate industry concentration, with key producers in China and North America.
  • Future growth hinges on innovation in medical applications and sustainable sourcing.

FAQs

1. What are the main medical uses of sodium iodide?
It functions as a radiocontrast agent and in nuclear medicine for thyroid imaging and treatment with radioactive iodine isotopes.

2. How does iodine availability affect sodium iodide prices?
Iodine supply disruptions elevate raw material costs, impacting sodium iodide prices directly.

3. What regulatory bodies govern pharmaceutical-grade sodium iodide?
The USP, EP, and Japan Pharmacopoeia set quality standards, with GMP requirements ensuring product safety and efficacy.

4. Which regions dominate sodium iodide production?
China, the United States, and Japan are the primary producers, controlling significant portions of global supply.

5. What future trends could influence the sodium iodide market?
Research into new applications, alternative sourcing methods, and environmental regulations could reshape supply chains and demand.


Citations:
[1] Mordor Intelligence, 2022. "Global Sodium Iodide Market Insights."
[2] U.S. Pharmacopeia. Pharmaceutical Standards for Iodides.
[3] European Pharmacopoeia. Standards for Radioactive Iodides.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.